I agree that this site is using cookies. You can find further informations here.
X
Yoo, Changhoon
599  results:
Search for persons X
?
1

Adverse Events as Potential Predictive Factors of Activity ..:

Persano, Mara ; Rimini, Margherita ; Tada, Toshifumi...
Targeted Oncology.  , 2024
Link: https://doi.org/10.1007/..
 
?
2

[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high..:

Singh, Simron ; Halperin, Daniel ; Myrehaug, Sten...
The Lancet.  , 2024
Link: https://doi.org/10.1016/..
 
?
3

Expansion of tumor-infiltrating lymphocytes in non-small ce..:

Lee, Hyun ; Lee, Miseon ; Lim, Chae Lyul...
Clinical Immunology.  265 (2024)  - p. 110289 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Clinical practice recommendations for the use of next-gener..:

Kim, Miso ; Shim, Hyo Sup ; Kim, Sheehyun...
Journal of Pathology and Translational Medicine.  , 2024
Link: https://doi.org/10.4132/..
 
?
5

Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 9078..:

Yoo, Changhoon ; Lamarca, Angela ; Choi, Hye Jin...
Future Oncology.  20 (2024)  16 - p. 1069-1077 , 2024
Link: https://doi.org/10.2217/..
 
?
6

Impact of body mass index on the prognosis of unresectable ..:

Rimini, Margherita ; Stefanini, Bernardo ; Tada, Toshifumi...
Liver International.  44 (2024)  5 - p. 1108-1125 , 2024
Link: https://doi.org/10.1111/..
 
?
7

Prediction of [177Lu]Lu-DOTA-TATE therapy response using th..:

Ha, Sejin ; Kim, Yong-il ; Oh, Jungsu S....
EJNMMI Physics.  11 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
8

Multicentre phase II trial of cabozantinib in patients with..:

Chan, Stephen L. ; Ryoo, Baek-Yeol ; Mo, Frankie...
Journal of Hepatology.  , 2024
Link: https://doi.org/10.1016/..
 
?
9

Practice guidelines for managing extrahepatic biliary tract..:

Kim, Hyung Sun ; Kang, Mee Joo ; Kang, Jingu...
Annals of Hepato-Biliary-Pancreatic Surgery.  28 (2024)  2 - p. 161-202 , 2024
Link: https://doi.org/10.14701..
 
?
10

Disease Etiology Impact on Outcomes of Hepatocellular Carci..:

Rossari, Federico ; Tada, Toshifumi ; Suda, Goki...
Liver Cancer.  , 2024
Link: https://doi.org/10.1159/..
 
?
11

Organ-specific response with first-line atezolizumab-bevaci..:

Kim, Hyung-Don ; Park, Young-Gyu ; Kim, Sejin...
Hepatology International.  18 (2024)  3 - p. 973-983 , 2024
Link: https://doi.org/10.1007/..
 
?
12

Clinical outcomes of second-line therapy following disease ..:

Yoon, Hyunseok ; Shin, Yeokyeong ; Ryoo, Baek-Yeol...
Pancreatology.  24 (2024)  3 - p. 424-430 , 2024
Link: https://doi.org/10.1016/..
 
?
13

Bintrafusp alfa and chemotherapy as first-line treatment in..:

Oh, Do-Youn ; Ikeda, Masafumi ; Lee, Choong-kun...
Hepatology.  , 2024
Link: https://doi.org/10.1097/..
 
?
14

Safety and Efficacy of Lenvatinib in Very Old Patients with..:

Camera, Silvia ; Rimini, Margherita ; Rossari, Federico...
Targeted Oncology.  19 (2024)  1 - p. 29-39 , 2024
Link: https://doi.org/10.1007/..
 
?
15

Regorafenib plus nivolumab in unresectable hepatocellular c..:

Kim, Hyung-Don ; Jung, Seyoung ; Lim, Ho Yeong...
Nature Medicine.  30 (2024)  3 - p. 699-707 , 2024
Link: https://doi.org/10.1038/..
 
1-15